Clarification in respect of Exercise Price and Vesting Criteria for all the grants under Aequs Employee Stock Option Plan 2025 ( ESOP 2025 )

Aequs Limited has issued a clarification on its Employee Stock Option Plan 2025 (ESOP 2025) in response to feedback from proxy advisors who raised concerns about lack of clarity on exercise price and vesting criteria. The company clarified that the exercise price for all ESOP 2025 grants will be the last traded price of Aequs shares on the stock exchange with the highest trading volume, on the trading day immediately before the grant date — making it market-linked and transparent. For vesting, the company follows a mix of time-based vesting (historically 50% of options vest over 5 years at 10% per year) and performance-based vesting tied to revenue, EBITDA, PAT, and other metrics set by the Nomination & Remuneration Committee (NRC), with the total vesting period typically ranging from 5 to 7 years. This clarification is supplementary to the Postal Ballot Notice dated February 25, 2026, which seeks shareholder approval for ratification and amendment of ESOP 2025.